AI-Powered Hippocampal Segmentation and Alzheimer’s Disease

The use of artificial intelligence (AI) for hippocampal segmentation on brain magnetic resonance imaging (MRI) offers “excellent diagnostic accuracy” for differentiating between normal findings and Alzheimer’s disease, according to the authors of a new meta-analysis. The reduced capability with MCI differentiation suggests that other markers beyond hippocampal segmentation are necessary to bolster clarity with early-stage neurodegeneration.